Free Trial

Desjardins Brokers Boost Earnings Estimates for KP Tissue

KP Tissue logo with Consumer Defensive background

Key Points

  • Desjardins raised its Q3 2025 EPS estimate for KP Tissue from $0.13 to $0.21, maintaining a "Hold" rating with a price target of $10.00.
  • KP Tissue has announced a quarterly dividend of $0.18 per share, which results in an annualized dividend yield of 7.5%.
  • TD Securities and National Bankshares have increased their price targets for KP Tissue to C$9.00 and C$10.00, respectively, both giving the stock a "hold" rating.
  • Need better tools to track KP Tissue? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

KP Tissue Inc. (TSE:KPT - Free Report) - Investment analysts at Desjardins raised their Q3 2025 earnings estimates for shares of KP Tissue in a research report issued on Wednesday, August 13th. Desjardins analyst F. Tremblay now anticipates that the company will post earnings per share of $0.21 for the quarter, up from their previous estimate of $0.13. Desjardins has a "Hold" rating and a $10.00 price target on the stock. The consensus estimate for KP Tissue's current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue's FY2025 earnings at $0.82 EPS.

KPT has been the topic of several other reports. TD Securities raised their price objective on KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a research note on Thursday, May 22nd. National Bankshares raised their target price on KP Tissue from C$9.50 to C$10.00 and gave the company a "sector perform" rating in a research note on Thursday, August 14th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of C$9.38.

Check Out Our Latest Stock Analysis on KPT

KP Tissue Stock Down 0.6%

Shares of KPT traded down C$0.06 during midday trading on Monday, reaching C$9.57. 6,722 shares of the stock were exchanged, compared to its average volume of 16,410. The stock's 50 day simple moving average is C$9.19 and its 200 day simple moving average is C$8.55. KP Tissue has a twelve month low of C$7.54 and a twelve month high of C$9.69. The company has a market cap of C$95.64 million, a P/E ratio of 14.98, a PEG ratio of -0.88 and a beta of 0.37.

KP Tissue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 7.5%. KP Tissue's payout ratio is presently 112.73%.

About KP Tissue

(Get Free Report)

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.

See Also

Should You Invest $1,000 in KP Tissue Right Now?

Before you consider KP Tissue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.

While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines